三价核苷修饰mRNA脂质纳米颗粒疫苗预防新生儿小鼠2型单纯疱疹病毒感染
研究在雌性小鼠交配前分别用mRNA或蛋白疫苗免疫,新生小鼠经鼻感染HSV-2,评估两种疫苗对新生儿疱疹的保护效果。母鼠和新生鼠的IgG结合与中和抗体水平在两种疫苗间相当,两者均能保护第一和第二窝新生鼠免受多器官播散性感染。作者认为两种疫苗均有效,但基于mRNA疫苗对生殖器疱疹更好的保护效果,将其作为首选候选。
要点
- mRNA与蛋白疫苗诱导母鼠和新生鼠的IgG结合及中和抗体水平相当。
- 两种疫苗均保护第一和第二窝新生鼠免受多器官播散性感染。
- 基于对生殖器疱疹更优保护,mRNA疫苗为首选候选。
核心结论
- mRNA和蛋白疫苗均能有效预防新生小鼠疱疹病毒感染,mRNA疫苗因对生殖器疱疹保护更优而为首选候选。
研究设计与样本
- 雌性小鼠交配前免疫,新生小鼠经鼻感染HSV-2,比较mRNA与蛋白疫苗的保护效果。
主要发现
- 母鼠和新生鼠的IgG结合与中和抗体水平在mRNA或蛋白疫苗间相当。
- 两种疫苗均保护第一和第二窝新生鼠免受基于多器官病毒滴度的播散性感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Neonatal herpes is a dreaded complication of genital herpes infection in pregnancy. We recently compared two vaccine platforms for preventing genital herpes in female mice and guinea pigs and determined that HSV-2 glycoproteins C, D and E expressed using nucleoside-modified mRNA in lipid nanoparticles provided better protection than the same antigens produced as baculovirus proteins and administered with CpG and alum. Here we evaluated mRNA and protein immunization for protection against neonatal herpes. Female mice were immunized prior to mating and newborns were infected intranasally with HSV-2. IgG binding and neutralizing antibody levels in mothers and newborns were comparable using the mRNA or protein vaccines. Both vaccines protected first and second litter newborns against disseminated infection based on virus titers in multiple organs. We conclude that both vaccines are efficacious at preventing neonatal herpes, which leaves the mRNA vaccine as our preferred candidate based on better protection against genital herpes.
引用
- LaTourette PC, Awasthi S, Desmond A, et al. Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine. Vaccine. 2020. PMID: 33041105. doi:10.1016/j.vaccine.2020.09.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。